I can see it higher with the platform’s full potential.
For example all solid tumors and cost of $100K per treatment. Now we sell it for around $200K.
50% margin after manufacturing and operating costs yields $50K. All solid tumors say about 1 million.
(1 million times $50k)/ shares of 1.2 billion = $41.66 eps
I want to look ahead. It is why I chose to put money here. Otherwise something like LABU would be more my style at the bottom. It may be too soon for others to take this view.